BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CEACAM5, CEA AND Treatment
163 results:

  • 1. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
    Galanis E; Dooley KE; Keith Anderson S; Kurokawa CB; Carrero XW; Uhm JH; Federspiel MJ; Leontovich AA; Aderca I; Viker KB; Hammack JE; Marks RS; Robinson SI; Johnson DR; Kaufmann TJ; Buckner JC; Lachance DH; Burns TC; Giannini C; Raghunathan A; Iankov ID; Parney IF
    Nat Commun; 2024 Jan; 15(1):493. PubMed ID: 38216554
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Identification of CELSR3 and Other Potential cell Surface Targets in Neuroendocrine Prostate Cancer.
    Van Emmenis L; Ku SY; Gayvert K; Branch JR; Brady NJ; Basu S; Russell M; Cyrta J; Vosoughi A; Sailer V; Alnajar H; Dardenne E; Koumis E; Puca L; Robinson BD; Feldkamp MD; Winkis A; Majewski N; Rupnow B; Gottardis MM; Elemento O; Rubin MA; Beltran H; Rickman DS
    Cancer Res Commun; 2023 Aug; 3(8):1447-1459. PubMed ID: 37546702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mucinous cystadenocarcinoma of the ovary in a 14-year-old girl: a case report and literature review.
    Li Q; Zou C; Xu Y; Liu S; Yan T
    BMC Womens Health; 2023 Jul; 23(1):382. PubMed ID: 37479970
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ovarian strumal carcinoid: a case report.
    Kanasugi M; Nishiyama H; Sanpei M; Asano S; Honda T
    Fukushima J Med Sci; 2023 Apr; 69(1):51-55. PubMed ID: 36878591
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Other markers of medullary thyroid cancer, not only calcitonin.
    Censi S; Manso J; Mian C
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
    Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
    Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prospective study on the clinical relevance of
    Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
    Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation.
    Mulder EEAP; Smit L; Grünhagen DJ; Verhoef C; Sleijfer S; van der Veldt AAM; Uyl-de Groot CA
    ESMO Open; 2021 Dec; 6(6):100303. PubMed ID: 34781194
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A highly-specific fully-human antibody and CAR-T cells targeting CD66e/ceacam5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo.
    Baek DS; Kim YJ; Vergara S; Conard A; Adams C; Calero G; Ishima R; Mellors JW; Dimitrov DS
    Cancer Lett; 2022 Jan; 525():97-107. PubMed ID: 34740610
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma.
    Li Y; Gao Y; Chu W; Lv J; Li Z; Shi T
    Aging (Albany NY); 2021 Oct; 13(20):23672-23688. PubMed ID: 34675134
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Continued Discontinuation of TKI treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
    Brandenburg T; Tiedje V; Muchalla P; Theurer S; Weber F; Schmid KW; Dralle H; Führer D
    Front Endocrinol (Lausanne); 2021; 12():718418. PubMed ID: 34659114
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
    Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
    Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (cea) Values in Patients with Medullary Thyroid Carcinoma (MTC).
    Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
    [No Abstract]    [Full Text] [Related]  

  • 16. Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.
    Kazemi Shariat Panahi H; Dehhaghi M; Lam SS; Peng W; Aghbashlo M; Tabatabaei M; Guillemin GJ
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1122-1142. PubMed ID: 34004331
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma.
    Giovanella L; Fontana M; Keller F; Campenni' A; Ceriani L; Paone G
    Clin Chem Lab Med; 2021 Aug; 59(9):1569-1573. PubMed ID: 33860650
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
    Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
    J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
    Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
    Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
    Jozaghi Y; Zafereo M; Williams MD; Gule-Monroe MK; Wang J; Grubbs EG; Vaporciyan A; Hu MI; Busaidy N; Dadu R; Waguespack SG; Subbiah V; Cabanillas M
    Head Neck; 2021 Jan; 43(1):E7-E12. PubMed ID: 33169506
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.